MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

PRIMARY OBJECTIVES:

I. To evaluate the frequency of use of meditation (a stress management technique) among breast cancer survivors.

II. To evaluate the feasibility of a wearable EEG headband, MUSE S, together with smartphone or tablet application (app) to guide breast cancer survivors' interactive meditation and sleep support.

III. To measure the impact of interactive meditation and sleep support through MUSE S among breast cancer survivors during or after chemotherapy on improving symptoms of anxiety and insomnia.

OUTLINE:

Patients wear the MUSE S headband to bed every night for 8 weeks and meditate using the MUSE phone app during day hours for at least 5 minutes over 8 weeks.

Inclusion criteria

• Age between 18-80
• Breast cancer first diagnosed with stage 1-4 breast cancer in the past 10 years
• Patients report experiencing anxiety and insomnia both rated > 3 on a 0-10 scale (with 0 indicating none) at the time of enrollment
• Patients on anti-anxiety/anti-depressant medication must be on stable dose for 1 month prior to study enrollment and must stay on that same dose throughout the trial
• Has smart phone or tablet
• Patient willing to use Google-based anonymous email account to sign up for MUSE
• Be willing to provide informed consent and complete all aspects of the study
• Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-S (trademark) system, as determined by the clinical investigators

Exclusion criteria

• Pregnant or breastfeeding individuals
• Individuals who have used a regular mindfulness practice or received integrative medicine therapy, including acupuncture/acupressure, mindfulness or stress-reduction programs, massage, and/or energy therapies within the past 60 days
• Currently taking medication for insomnia
• An exclusionary unstable medical or mental health condition as determined by the patient's oncologist